TrakCel recently announced the launch of its latest platform. Paul Viggers, Chief Commercial Officer at TrakCel, explains how it fits into the drug discovery and development sector.   The catalysts  Ten years ago, cell and gene therapy (CGT) was really finding its feet as success stories such as that of Emily Whitehead began to hit the news.1 […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!